RE:RE:RE:RE:NHC reported today... down 20%Most big companies do with all the time.... the buyout becomes Accreitve at the big companies multiple which is higher than the company they are taking over. On top of that there are redundancies that are discarded and opportunities to grow. CXR having an international distribution abitlity is a key stratgegic advantage that they acquired. That's how M&A works. In CXR's model they are gaining a huge advantage by doing the deals they have done. They are not stripping down an existing company just for the cash flow.... They will see deals on drugs with an international scope. This will be huge for them.